Eps Summary of MedMira Inc.

MedMira Inc.'s latest annual eps in 2023 was -0.00 CAD , down -40.74% from previous year.
MedMira Inc.'s latest quarterly eps in 2024 Q2 was -0.00 CAD , up 27.27% from previous quarter.
MedMira Inc. reported an annual eps of -0.00 CAD in 2022, down -170.0% from previous year.
MedMira Inc. reported an annual eps of -0.00 CAD in 2021, up 67.74% from previous year.
MedMira Inc. reported a quarterly eps of -0.00 CAD for 2024 Q2, up 27.27% from previous quarter.
MedMira Inc. reported a quarterly eps of -0.00 CAD for 2024 Q1, up 21.43% from previous quarter.

Annual Eps Chart of MedMira Inc. (2023 - 2000)

Historical Annual Eps of MedMira Inc. (2023 - 2000)

Year	Eps	Eps Growth
2023	-0.00 CAD	-40.74%
2022	-0.00 CAD	-170.0%
2021	-0.00 CAD	67.74%
2020	-0.00 CAD	3.13%
2019	-0.00 CAD	20.0%
2018	-0.00 CAD	0.0%
2017	-0.00 CAD	50.0%
2016	-0.01 CAD	-37.93%
2015	-0.01 CAD	22.67%
2014	-0.01 CAD	-650.0%
2013	-0.00 CAD	-108.33%
2012	0.01 CAD	153.1%
2011	-0.02 CAD	3.83%
2010	-0.02 CAD	48.01%
2009	-0.05 CAD	47.26%
2008	-0.09 CAD	14.3%
2007	-0.10 CAD	33.33%
2006	-0.15 CAD	-7.14%
2005	-0.14 CAD	-40.0%
2004	-0.10 CAD	44.44%
2003	-0.18 CAD	33.33%
2002	-0.27 CAD	22.86%
2001	-0.35 CAD	-150.0%
2000	-0.14 CAD	0.0%

Year	Eps	Eps Growth
2024 Q3	-0.00 CAD	-37.5%
2024 Q2	-0.00 CAD	27.27%
2024 Q1	-0.00 CAD	21.43%
2023 Q1	-0.00 CAD	-28.57%
2023 FY	- CAD	-40.74%
2023 Q2	-0.00 CAD	22.22%
2023 Q3	-0.00 CAD	-14.29%
2023 Q4	-0.00 CAD	-75.0%
2022 Q4	-0.00 CAD	-16.67%
2022 Q3	-0.00 CAD	14.29%
2022 FY	- CAD	-170.0%
2022 Q1	-0.00 CAD	30.0%
2022 Q2	-0.00 CAD	0.0%
2021 Q3	-0.00 CAD	16.67%
2021 Q1	0.00 CAD	350.0%
2021 Q2	-0.00 CAD	-160.0%
2021 FY	- CAD	67.74%
2021 Q4	-0.00 CAD	-100.0%
2020 Q1	-0.00 CAD	0.0%
2020 Q3	-0.00 CAD	-22.22%
2020 Q2	-0.00 CAD	-28.57%
2020 FY	- CAD	3.13%
2020 Q4	-0.00 CAD	63.64%
2019 FY	- CAD	20.0%
2019 Q1	-0.00 CAD	20.0%
2019 Q2	-0.00 CAD	-12.5%
2019 Q3	-0.00 CAD	11.11%
2019 Q4	-0.00 CAD	12.5%
2018 Q1	-0.00 CAD	-25.0%
2018 FY	- CAD	0.0%
2018 Q4	-0.00 CAD	0.0%
2018 Q3	-0.00 CAD	9.09%
2018 Q2	-0.00 CAD	-10.0%
2017 Q2	-0.00 CAD	33.33%
2017 FY	- CAD	50.0%
2017 Q4	-0.00 CAD	27.27%
2017 Q3	-0.00 CAD	-37.5%
2017 Q1	-0.00 CAD	63.64%
2016 Q1	-0.00 CAD	-180.0%
2016 FY	- CAD	-37.93%
2016 Q2	-0.00 CAD	-7.14%
2016 Q3	-0.00 CAD	-20.0%
2016 Q4	-0.00 CAD	-83.33%
2015 Q4	-0.00 CAD	66.67%
2015 Q3	-0.00 CAD	25.0%
2015 FY	- CAD	22.67%
2015 Q2	-0.00 CAD	0.0%
2015 Q1	-0.00 CAD	-300.0%
2014 Q4	-0.00 CAD	79.17%
2014 FY	- CAD	-650.0%
2014 Q3	-0.00 CAD	14.29%
2014 Q1	-0.00 CAD	0.0%
2014 Q2	-0.00 CAD	-40.0%
2013 Q4	-0.00 CAD	9.09%
2013 Q2	0.00 CAD	200.0%
2013 Q1	0.00 CAD	0.0%
2013 Q3	-0.00 CAD	-173.33%
2013 FY	- CAD	-108.33%
2012 FY	- CAD	153.1%
2012 Q1	-0.01 CAD	0.0%
2012 Q2	-0.01 CAD	-31.51%
2012 Q4	- CAD	100.0%
2012 Q3	-0.01 CAD	36.46%
2011 Q4	- CAD	100.0%
2011 FY	- CAD	3.83%
2011 Q2	-0.01 CAD	-9.09%
2011 Q1	-0.01 CAD	0.0%
2011 Q3	-0.00 CAD	31.67%
2010 FY	- CAD	48.01%
2010 Q4	- CAD	100.0%
2010 Q3	-0.00 CAD	22.5%
2010 Q2	-0.00 CAD	43.66%
2010 Q1	-0.01 CAD	0.0%
2009 Q3	-0.01 CAD	13.0%
2009 Q2	-0.01 CAD	42.53%
2009 Q1	-0.02 CAD	0.0%
2009 FY	- CAD	47.26%
2009 Q4	- CAD	100.0%
2008 Q1	-0.02 CAD	0.0%
2008 FY	- CAD	14.3%
2008 Q4	- CAD	100.0%
2008 Q3	-0.02 CAD	-110.13%
2008 Q2	-0.01 CAD	62.74%
2007 Q4	- CAD	100.0%
2007 Q2	-0.03 CAD	-1.58%
2007 FY	- CAD	33.33%
2007 Q3	-0.02 CAD	24.9%
2007 Q1	-0.03 CAD	0.0%
2006 Q3	-0.05 CAD	-76.49%
2006 Q4	- CAD	100.0%
2006 FY	- CAD	-7.14%
2006 Q1	-0.04 CAD	0.0%
2006 Q2	-0.03 CAD	33.83%
2005 Q1	-0.03 CAD	0.0%
2005 Q2	-0.03 CAD	-18.15%
2005 Q3	-0.03 CAD	6.93%
2005 Q4	- CAD	100.0%
2005 FY	- CAD	-40.0%
2004 Q2	-0.02 CAD	-7.39%
2004 Q4	- CAD	100.0%
2004 FY	- CAD	44.44%
2004 Q1	-0.02 CAD	0.0%
2004 Q3	-0.03 CAD	-12.96%
2003 Q2	-0.05 CAD	-7.73%
2003 Q4	- CAD	100.0%
2003 Q3	-0.07 CAD	-41.77%
2003 FY	- CAD	33.33%
2003 Q1	-0.04 CAD	0.0%
2002 Q2	-0.05 CAD	21.7%
2002 Q1	-0.06 CAD	0.0%
2002 FY	- CAD	22.86%
2002 Q3	-0.05 CAD	-18.4%
2002 Q4	- CAD	100.0%
2001 FY	- CAD	-150.0%
2000 FY	- CAD	0.0%

Peer Eps Comparison of MedMira Inc.

Name	Eps	Eps Difference
Bioxytran, Inc.	-0.03 USD	87.461%
Eiger BioPharmaceuticals, Inc.	-50.78 USD	99.992%
Institute of Biomedical Research Corp.	-0.05 USD	92.233%
SQZ Biotechnologies Company	-2.76 USD	99.855%
Intellipharmaceutics International Inc.	-0.09 USD	95.423%
Evofem Biosciences, Inc.	10.35 USD	100.039%
Santhera Pharmaceuticals Holding AG	5.95 USD	100.067%
Propanc Biopharma, Inc.	-0.02 USD	83.122%
Marizyme, Inc.	-1.44 USD	99.722%
Genus plc	0.12 USD	103.333%
Pharming Group N.V.	-0.02 USD	75.155%
Therapeutic Solutions International, Inc.	-0.00 USD	-471.429%
CNBX Pharmaceuticals Inc.	-0.42 USD	99.048%
Nymox Pharmaceutical Corporation	-0.10 USD	95.855%
ContraFect Corporation	-124.97 USD	99.997%
RegeneRx Biopharmaceuticals, Inc.	-0.01 USD	66.667%
IMV Inc.	-4.37 USD	99.908%
AXIM Biotechnologies, Inc.	-0.04 USD	88.701%
ONE Bio Corp.	1.43 USD	100.28%
RVL Pharmaceuticals plc	-0.58 USD	99.31%
Mesoblast Limited	-0.09 USD	95.511%
MultiCell Technologies, Inc.	-0.00 USD	-3900.0%
Arno Therapeutics, Inc.	- USD	Infinity%
Emmaus Life Sciences, Inc.	-0.07 USD	94.31%
Genscript Biotech Corporation	-0.05 USD	91.189%
Neon Bloom, Inc.	-0.00 USD	-166.667%
Mosaic ImmunoEngineering Inc.	-0.33 USD	98.788%
Nanobac Pharmaceuticals, Incorporated	- USD	Infinity%
Biomind Labs Inc.	-0.02 USD	75.309%
Provectus Biopharmaceuticals, Inc.	-0.01 USD	45.946%
Oncotelic Therapeutics, Inc.	-0.02 USD	79.899%
Skye Bioscience, Inc.	-5.37 USD	99.926%
GlobeStar Therapeutics Corporation	-0.00 USD	-66.667%
VioQuest Pharmaceuticals, Inc.	-2.33 USD	99.828%
THC Farmaceuticals, Inc.	-0.00 USD	-400.0%
PsyBio Therapeutics Corp.	-0.04 USD	90.476%
Arch Therapeutics, Inc.	-2.27 USD	99.824%
Sienna Biopharmaceuticals, Inc.	- USD	Infinity%
Acro Biomedical Co., Ltd.	-0.26 USD	98.462%
Accustem Sciences Inc.	-0.34 USD	98.824%
EV Biologics, Inc.	-0.12 USD	96.667%
Q BioMed Inc.	-0.08 USD	94.878%
GB Sciences, Inc.	-0.00 USD	2.439%
Alpha Cognition Inc.	-0.15 USD	97.333%
CSL Limited	2.73 USD	100.147%
Agentix Corp.	-0.04 USD	88.571%
American Oriental Bioengineering, Inc.	-781.24 USD	99.999%
Enzolytics Inc.	-0.00 USD	-471.429%
TetraLogic Pharmaceuticals Corporation	- USD	Infinity%
Resverlogix Corp.	-0.01 USD	71.831%
Nuo Therapeutics, Inc.	-0.08 USD	94.695%
MetaStat, Inc.	- USD	Infinity%
Curative Biotechnology, Inc.	-0.01 USD	54.545%
argenx SE	-5.16 USD	99.922%
Northwest Biotherapeutics, Inc.	-0.06 USD	93.043%
HST Global, Inc.	-0.03 USD	85.663%
Enzon Pharmaceuticals, Inc.	0.00 USD	407.692%
Wesana Health Holdings Inc.	-0.05 USD	92.016%
Halberd Corporation	-0.00 USD	-3900.0%
Endonovo Therapeutics, Inc.	0.03 USD	115.936%
Inhibitor Therapeutics, Inc.	-0.02 USD	80.0%
Zenith Capital Corp.	-0.07 USD	94.278%
RespireRx Pharmaceuticals Inc.	-0.04 USD	88.796%
GeneThera, Inc.	- USD	Infinity%
Sigyn Therapeutics, Inc.	-3.77 USD	99.894%
AVAX Technologies, Inc.	-0.05 USD	92.579%
WPD Pharmaceuticals Inc.	-0.00 USD	-700.0%
Cotinga Pharmaceuticals Inc.	-0.09 USD	95.619%
Ember Therapeutics, Inc.	-0.01 USD	36.508%
Anthera Pharmaceuticals, Inc.	- USD	Infinity%
Adynxx, Inc.	- USD	Infinity%
NovAccess Global Inc.	-0.23 USD	98.261%
Helix BioMedix, Inc.	-4.70 USD	99.915%
Capstone Therapeutics Corp.	-36.39 USD	99.989%
Kadimastem Ltd	-0.78 USD	99.487%
VitaSpring Biomedical Co. Ltd.	- USD	Infinity%
BioStem Technologies, Inc.	-0.62 USD	99.355%
Oncology Pharma Inc.	- USD	Infinity%
Reve Technologies, Inc.	-0.01 USD	66.387%
Burzynski Research Institute, Inc.	-0.01 USD	60.784%
LadRx Corporation	0.68 USD	100.588%
Cell Source, Inc.	-0.17 USD	97.647%
ProtoKinetix, Incorporated	-0.01 USD	60.0%
Regen BioPharma, Inc.	0.29 USD	101.379%
Regen BioPharma, Inc.	0.26 USD	101.538%
Affymax, Inc.	-0.39 USD	98.974%
Mobile Lads Corp.	-0.01 USD	28.571%
Itoco Inc.	-0.01 USD	47.368%
Rasna Therapeutics, Inc.	-0.01 USD	60.0%
Pathfinder Cell Therapy, Inc.	-0.00 USD	-60.0%
International Stem Cell Corporation	-0.02 USD	75.61%
CytoDyn Inc.	-0.05 USD	92.439%
Claritas Pharmaceuticals, Inc.	- USD	Infinity%
NDT Pharmaceuticals Inc.	-0.00 USD	-700.0%
NanoSphere Health Sciences Inc.	-0.02 USD	81.982%
Qrons Inc.	-0.06 USD	93.139%
Alseres Pharmaceuticals, Inc.	-153.67 USD	99.997%
SYBLEU INC	-0.02 USD	77.143%
Advanced Proteome Therapeutics Corporation	- USD	Infinity%
Nascent Biotech, Inc.	-0.01 USD	70.149%
Rebus Holdings, Inc.	-0.03 USD	87.539%
GlobeImmune, Inc.	- USD	Infinity%
ImmunoCellular Therapeutics, Ltd.	-0.01 USD	71.831%
Predictive Technology Group, Inc.	- USD	Infinity%
ProText Mobility, Inc.	- USD	Infinity%
Cardax, Inc.	- USD	Infinity%
VG Life Sciences Inc.	-0.00 USD	-3900.0%
Kaleido Biosciences, Inc.	- USD	Infinity%
Advaxis, Inc.	-7.99 USD	99.95%
Adhera Therapeutics, Inc.	-1.18 USD	99.661%
RenovaCare, Inc.	- USD	Infinity%
Regnum Corp.	-0.03 USD	88.235%
Innovation Pharmaceuticals Inc.	-0.01 USD	36.508%
Neutra Corp.	-0.00 USD	-3900.0%
Windtree Therapeutics, Inc.	-94.23 USD	99.996%
PureTech Health plc	-2.38 USD	99.832%
Coeptis Therapeutics, Inc.	-0.83 USD	99.518%
IXICO plc	-0.02 USD	83.607%
IntelGenx Technologies Corp.	-0.06 USD	92.958%
Gelesis Holdings, Inc.	-1.35 USD	99.704%
CSL Limited	5.47 USD	100.073%
Cellectis S.A.	-1.77 USD	99.774%

Global Stocks Search

MedMira Inc. (MMIRF)

Eps Summary of MedMira Inc.

Annual Eps Chart of MedMira Inc. (2023 - 2000)

Historical Annual Eps of MedMira Inc. (2023 - 2000)

Peer Eps Comparison of MedMira Inc.